FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 18 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $31,000 | – | 34,786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,997,620 | $19,307,000 | 27.43% |
| CHI Advisors LLC | 4,862,319 | $4,230,000 | 1.62% |
| TFG Asset Management GP Ltd | 3,760,508 | $3,272,000 | 0.22% |
| Eventide Asset Management | 5,950,000 | $5,168,000 | 0.11% |
| HARBOR CAPITAL ADVISORS, INC. | 146,562 | $129,000 | 0.10% |
| Values First Advisors, Inc. | 56,300 | $49,000 | 0.04% |
| MORGAN STANLEY | 192,943 | $168,000 | 0.00% |
| SG Americas Securities, LLC | 51,663 | $45,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 26,963 | $23,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34,786 | $31,000 | 0.00% |